Clinical trial
ZD0473 in Treating Patients With Progressive or Relapsed Non-Small Lung Cancer
NCT00021008 · Jonsson Comprehensive Cancer Center, Other · Unknown status
Key facts
| NCT number | NCT00021008 |
|---|---|
| Title | ZD0473 in Treating Patients With Progressive or Relapsed Non-Small Lung Cancer |
| Official title | A Phase II Open, Multicenter Trial to Assess the Activity and Tolerability of ZD0473 Given Intravenously as Second-line Therapy to Patients With Non-Small Lung Cancer Who Have Failed One Prior Platinum Based Chemotherapy Regimen |
| Lead sponsor | Jonsson Comprehensive Cancer Center, Other |
| Collaborators | National Cancer Institute (NCI) NIH |
| Status | Unknown status |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Lung Cancer |
| Intervention type | Drug |
| Interventions | picoplatin |
| First posted | Apr 13, 2004 |
| Last update posted | Dec 19, 2013 |
At a glance
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: